These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


175 related items for PubMed ID: 16760836

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Exacerbation of systemic lupus erythematosus induced by terbinafine.
    Holmes S, Kemmett D.
    Br J Dermatol; 1998 Dec; 139(6):1133. PubMed ID: 9990401
    [No Abstract] [Full Text] [Related]

  • 7. [Cutaneous lupus erythematosus induced by terbinafine].
    Møller M, Bygum A.
    Ugeskr Laeger; 2006 Dec 11; 168(50):4427-8. PubMed ID: 17217873
    [Abstract] [Full Text] [Related]

  • 8. Terbinafine-induced subacute cutaneous lupus erythematosus.
    Farhi D, Viguier M, Cosnes A, Reygagne P, Dubertret L, Revuz J, Roujeau JC, Bachelez H.
    Dermatology; 2006 Dec 11; 212(1):59-65. PubMed ID: 16319476
    [Abstract] [Full Text] [Related]

  • 9. Subacute cutaneous lupus erythematosus in a patient with Sjögren's syndrome taking terbinafine for onychomycosis.
    Madeira N, Silva C, Cunha-Miranda L.
    Acta Reumatol Port; 2020 Dec 11; 45(4):288-292. PubMed ID: 33420774
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Severe Rowell syndrome associated with oral terbinafine.
    Champagne C, Ratnavel R, Wong T.
    Clin Exp Dermatol; 2012 Oct 11; 37(7):822-3. PubMed ID: 22998546
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Terbinafine-induced subacute cutaneous lupus erythematosus.
    Brooke R, Coulson IH, al-Dawoud A.
    Br J Dermatol; 1998 Dec 11; 139(6):1132-3. PubMed ID: 9990400
    [No Abstract] [Full Text] [Related]

  • 17. [Terbinafine-induced subacute cutaneous lupus erythematosus. Case report and review of the literature].
    Matthes T, Hagedorn M.
    Hautarzt; 2004 Jul 11; 55(7):653-7. PubMed ID: 15146276
    [Abstract] [Full Text] [Related]

  • 18. Griseofulvin and/or Terbinafine Induced Toxic Epidermal Necrolysis in an Adult Female Patient - A Case Report.
    Jadeja D, Jaiswal CS, Panchasra A, Tripathi CB.
    Curr Drug Saf; 2016 Jul 11; 11(2):192-4. PubMed ID: 26695069
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Subacute cutaneous lupus erythematosus induced by terbinafine: case report and review of literature.
    Lorentz K, Booken N, Goerdt S, Goebeler M.
    J Dtsch Dermatol Ges; 2008 Oct 11; 6(10):823-7, 823-8. PubMed ID: 18564209
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.